SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-17-000043
Filing Date
2017-05-03
Accepted
2017-05-03 16:12:34
Documents
18
Period of Report
2017-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201705038xkdoc.htm 8-K 33103
2 PRESS RELEASE pdli-201705038xkex991.htm EX-99.1 162452
3 PRESENTATION pdli-201705038xkex992.htm EX-99.2 6371
4 INFORMATION SHEET pdli-201705038xkex993.htm EX-99.3 243633
5 pdllogo2016a09.jpg GRAPHIC 5218
6 slide1a42.jpg GRAPHIC 42721
7 slide2a42.jpg GRAPHIC 246878
8 slide3a42.jpg GRAPHIC 124642
9 slide4a42.jpg GRAPHIC 89987
10 slide5a42.jpg GRAPHIC 147089
11 slide6a42.jpg GRAPHIC 149108
12 slide7a42.jpg GRAPHIC 107553
13 slide8a40.jpg GRAPHIC 143578
14 slide9a38.jpg GRAPHIC 198719
15 slidk49.jpg GRAPHIC 144279
16 slidk50.jpg GRAPHIC 112975
17 slidk51.jpg GRAPHIC 153389
18 slidk52.jpg GRAPHIC 32334
  Complete submission text file 0000882104-17-000043.txt   2787139
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 17809289
SIC: 2836 Biological Products, (No Diagnostic Substances)